Cramlington firm starts work on first of its kind plant
Work has started on a cutting-edge bioplant enhancement plant.
Dudley-based pharmaceutical manufacturing company Sterling Pharma Solutions has begun construction at its Cramlington site to boost the sustainability of its operations and contribute to the UK’s green gas initiative for action against climate change.
The first of its kind in the UK, the anaerobic plant will use micro-organisms to form biogas from liquid waste produced during its manufacturing operations which will then be purified to produce biomethane that will be injected back in the national gas grid.
Brian Peutherer, HSE Director at Sterling, said: “Sterling aspires towards a carbon-neutral operation.
"Our recent carbon footprint assessment shows that this is within our grasp, and our bioplant investment is a major step along this journey.
"We will be supplying low-carbon energy to the local distribution grid, which will ultimately benefit the environment and the community. This project is one of many that will enhance sustainability on our site and lead to a cleaner, greener Northumberland.”
In addition, by processing more waste on site, the bioplant will reduce vehicle movements from the facility by the equivalent of 90 HGVs per year, taking vehicles off the road and saving a further 55 tonnes of carbon dioxide annually.
The enhanced bioplant is being developed in partnership with Synergie Environ Ltd (SEL).
Uisdean Fraser, Managing Director at SEL, added: “This is a real first for the UK and we’re delighted to be able to support Sterling as it plays its part in reducing the environmental footprint of pharmaceutical manufacturing, and the country as a whole.”
Work on the new facility commenced in December 2020 and will be fully commissioned by March 2022.